BDX

BD Named a Best Employer for Excellence in Employee Well-Being

Retrieved on: 
Tuesday, April 9, 2024
Well, American Heart Association, Health, Culture, Job satisfaction, Health equity, BDX, Mental health, Cigna, Gold, Workforce, Safety, Management

BD also garnered honors for "Excellence in Global Health & Well-being" for its ability to meet the diverse needs of employees in multiple countries and its commitment to equity, with a set of standard benefits offerings.

Key Points: 
  • BD also garnered honors for "Excellence in Global Health & Well-being" for its ability to meet the diverse needs of employees in multiple countries and its commitment to equity, with a set of standard benefits offerings.
  • "Our integrated approach focuses on physical, emotional, financial and social well-being, and empowers our people to thrive—personally and professionally."
  • This award is the latest accolade for BD employee well-being efforts.
  • Additionally, the American Heart Association awarded BD a Gold level recognition for its commitments to employee health and well-being as measured in the Association's 2023 Well-being Works Better Scorecard.

BD Increases Access to Cutting-Edge Image-Enabled, Spectral Cell Sorters

Retrieved on: 
Friday, April 5, 2024
Genomics, Flow cytometry, Cell, Drug discovery, Laser, BDX, Cell biology, Research, Science, Workflow, AACR, EMBL, Family

FRANKLIN LAKES, N.J., April 5, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new cell sorters that will enable more researchers in a broader range of fields, including cell biology, cancer research and immunology, to reveal insights that were previously invisible in traditional flow cytometry experiments.

Key Points: 
  • The new BD FACSDiscover™ S8 Cell Sorters feature BD CellView™ Image Technology, profiled on the cover of the journal Science in 2022, and BD SpectralFX™ Technology — bringing to market breakthrough innovations in real-time imaging and spectral flow cytometry.
  • The three- and four-laser additions to the BD FACSDiscover™ S8 Cell Sorter family complement the five-laser instrument launched last year and provide scientists greater access, options, and flexibility to incorporate real-time imaging and spectral cell sorting technology in their labs.
  • "It has the same sorting speed and software capabilities as the five-laser unit, making experiments extremely scalable on an easy-to-use instrument."
  • The family of BD FACSDiscover™ Cell Sorters will be featured at upcoming conferences beginning with the American Association for Cancer Research (AACR) Annual Meeting, April 5-10, and is now available to order through local sales representatives.

BD to Announce Financial Results for its Second Quarter of Fiscal 2024

Retrieved on: 
Thursday, April 4, 2024
BDX, News

FRANKLIN LAKES, N.J., April 4, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its second quarter of fiscal year 2024 on Thursday, May 2, 2024.

Key Points: 
  • FRANKLIN LAKES, N.J., April 4, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its second quarter of fiscal year 2024 on Thursday, May 2, 2024.
  • A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors , along with related presentation materials.
  • The news release and presentation materials will include summary financial information for the company's second quarter of fiscal year 2024, which ended on March 31, 2024.
  • ET on May 2, 2024 to discuss its financial results and provide an update on its operations and strategy.

Zonda Expands Building Products Database Through Acquisition of BDX and Envision Platform

Retrieved on: 
Monday, April 1, 2024
Principal, Forecasting, Intelligence, BDX, Builders hardware, Research, Acquisition, Retail

NEWPORT BEACH, Calif., April 1, 2024 /PRNewswire-PRWeb/ -- Zonda today announced the expansion of its building products research data capabilities and services as a result of the recent acquisition of BDX, including the leading new home listings platform, NewHomeSource.com, and the leading new home design platform, Envision. Envision empowers homebuyers by allowing them to view all the product options that are available for their new home and visualize their design selections before the home is built. Envision is a key addition to Zonda's comprehensive building products data and research strategy, providing insights into consumer choices and motivations.

Key Points: 
  • NEWPORT BEACH, Calif., April 1, 2024 /PRNewswire-PRWeb/ -- Zonda today announced the expansion of its building products research data capabilities and services as a result of the recent acquisition of BDX , including the leading new home listings platform, NewHomeSource.com , and the leading new home design platform, Envision.
  • Envision is a key addition to Zonda's comprehensive building products data and research strategy, providing insights into consumer choices and motivations.
  • –Todd Tomalak, Principal
    "The acquisition of Zonda and BDX is synergistic and will allow for a more holistic and comprehensive view of building products data," said Jeff Meyers, CEO of Zonda.
  • This integration allows Zonda to craft a unique and comprehensive narrative for the building products industry.

New Survey Reveals Patients Receive Too Many Needlesticks

Retrieved on: 
Wednesday, March 27, 2024
Health, The Harris Poll, Risk, BDX, Patient, Hospital, RNS, Standard of care, United, Needle, Intravenous therapy, Nursing

FRANKLIN LAKES, N.J., March 27, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the results of a new survey conducted by The Harris Poll that reveals that many patients receive too many needlesticks in hospital procedures and amplifies misconceptions and lack of awareness from Americans on the risks of common medical procedures.

Key Points: 
  • Needlesticks are an often-overlooked challenge but can be one of the most traumatic aspects of a patient's hospital stay.
  • Moreover, 77% of patients are unaware that regardless of what conditions they may have, patients should expect no more than two needlestick attempts from one clinician.
  • Unsurprisingly, the survey highlights strong concern from nurses on the impact of repeated needlesticks to the patient care experience.
  • A strong majority of nurses agree that repeated needlesticks negatively impact the patient experience and say that alternatives are needed to reduce the number of needlesticks patients encounter (92% and 91%, respectively).

BD Named Among Fortune's Most Innovative Companies

Retrieved on: 
Tuesday, March 26, 2024
BDX, Patient, Marketing, Standard of care, Entrepreneurship, Creativity, Management

FRANKLIN LAKES, N.J., March 26, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2024 list of America's Most Innovative Companies .

Key Points: 
  • FRANKLIN LAKES, N.J., March 26, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2024 list of America's Most Innovative Companies .
  • "At BD, innovation is about a mindset of excellence and continuous improvement, boldly challenging ourselves to think ahead and partnering with our customers to understand the evolving needs of the billions of patients around the world who rely on our health care products and solutions," said Tom Polen, chairman, CEO and president of BD.
  • Fortune and Statista surveyed more than 35,000 employees from eligible companies and 8,000 industry experts to rank companies across the three categories, in addition to evaluating a company's patents within the product innovation category.
  • Of the more than 25,000 U.S. companies considered, those with the highest 200 scores were named to Fortune's list of America's Most Innovative Companies .

BD and Health Care Consortium in Denmark Find Success in Medical Waste Recycling Study

Retrieved on: 
Monday, March 18, 2024
Odense University Hospital, Incineration, Biodegradable waste, Recycling, BDX, Single, PET, Research, Climate, Laboratory, Glass, Newsroom, Hygiene, Safety, Patient safety, Medical device

The study shows that these used tubes, which are made from high-quality polyethylene terephthalate (PET) plastic, can be cleaned, shredded and molded into other types of new articles.

Key Points: 
  • The study shows that these used tubes, which are made from high-quality polyethylene terephthalate (PET) plastic, can be cleaned, shredded and molded into other types of new articles.
  • "Single-use plastic revolutionized health care, but we know there are environmental considerations that come with this critical innovation," said Amit Limaye, director of the BD Sustainable Medical Technology Institute.
  • Used blood collection tubes are considered biohazardous and regulated medical waste, and in Denmark, they are currently disposed through incineration.
  • To learn more about this study, visit the website of Health Innovation Centre of Southern Denmark, and to learn more about BD's commitments to net zero emissions, visit the BD newsroom .

Zeus Names New Chief Executive Officer

Retrieved on: 
Thursday, March 14, 2024
Culture, Growth, BDX, Patient, Investment, EQT, Santa Clara University, Biology, Development

Zeus, a leading supplier of custom polymer components to the world's most innovative medical device and industrial companies, names Padraic "Paddy" O'Brien as new CEO

Key Points: 
  • Zeus, a leading supplier of custom polymer components to the world's most innovative medical device and industrial companies, names Padraic "Paddy" O'Brien as new CEO
    ORANGEBURG, S.C., March 14, 2024 /PRNewswire/ -- Zeus, the world's leading polymer extrusion and catheter design manufacturer, is excited to announce the appointment of Padraic "Paddy" O'Brien as Chief Executive Officer, effective April 1, 2024.
  • O'Brien joins Zeus at a pivotal moment as the company enters a new chapter of growth under EQT ownership.
  • "We are thrilled to welcome Paddy as the new CEO of Zeus," said John Groetelaars, Executive Chairman at Zeus.
  • His extensive experience and proven track record make him the ideal leader to steer Zeus through this exciting chapter of growth and advancement."

Zeus Names New Chief Executive Officer

Retrieved on: 
Thursday, March 14, 2024
Culture, Worldwide, Growth, BDX, Patient, Investment, EQT, Santa Clara University, Biology, Development

Zeus, a leading supplier of custom polymer components to the world's most innovative medical device and industrial companies, names Padraic "Paddy" O'Brien as new CEO

Key Points: 
  • Zeus, a leading supplier of custom polymer components to the world's most innovative medical device and industrial companies, names Padraic "Paddy" O'Brien as new CEO
    ORANGEBURG, S.C., March 14, 2024 /PRNewswire/ -- Zeus, the world's leading polymer extrusion and catheter design manufacturer, is excited to announce the appointment of Padraic "Paddy" O'Brien as Chief Executive Officer, effective April 1, 2024.
  • O'Brien joins Zeus at a pivotal moment as the company enters a new chapter of growth under EQT ownership.
  • "We are thrilled to welcome Paddy as the new CEO of Zeus," said John Groetelaars, Executive Chairman at Zeus.
  • His extensive experience and proven track record make him the ideal leader to steer Zeus through this exciting chapter of growth and advancement."

New Study Highlights Benefits of Medication Management Automation in Long-Term Care Facilities

Retrieved on: 
Wednesday, March 13, 2024
Yafa, Automation, American Pharmacists Association, BDX, Patient, Journal, Pharmacy, ADC, Nursing, Health

FRANKLIN LAKES, N.J., March 13, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new data from a research study evaluating the impact of deploying automated dispensing cabinets in long-term care facilities and an off-site, long-term care pharmacy.

Key Points: 
  • Over a 90-day period in the long-term care facilities, medication dispensing automation and the associated workflow changes led to a 71% reduction in medication retrieval time, as compared to manual emergency kits, improving medication availability when nurses used automation technology.
  • The study also showed a 96% reduction in the cost of unscheduled medication deliveries across the two long-term care facilities, representing $8,900 in cost savings.
  • "At BD, we recognize that the ever-changing health care landscape requires a safer, simpler and smarter approach to medication management," said Puneet Sarin, president of Medication Management Solutions for BD.
  • "With a rapidly growing population of older adults entering long-term care facilities, we must look to technology, like BD Pyxis™ MedBank™ automated dispensing cabinets, to manage operating costs, reduce the burden on health care providers and improve patient care."